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differences in the phenotypes be-
tween sema-1a and plexinA are ob-
served, raising the possibility that there
could be non-sema-1a-dependent
roles for plexinA in olfactory wiring.
Furthermore, it is important to point
out that although the most likely inter-
pretation of these findings is that Plex-
inA acts cell autonomously on axons
that receive Sema-1a signal, the inabil-
ity to analyze plexinA by MARCM
(plexinA is on the fourth chromosome
where MARCM is not possible) coun-
sels caution in definitively ascribing
PlexinA’s site of action.
In a final set of experiments, Swee-
ney et al. (2007) developed an inge-
niousmethod to independently manip-
ulate AT and MP ORNs to further
define the cellular mechanism of
Sema-1a action. By generating mutant
clones in both of the ATs and either
zero, one, or both MPs, coupled with
unilateral severing of MPs, the authors
established unambiguously that sema-
1a is required specifically on AT ORN
axons to regulate the targeting of ipsi-
lateral MP ORN axons within the an-
tennal lobe, while sema-1a is required
earlier in the MP ORN axons to regu-
late axon entry into the antennal lobe,
in a manner akin to that proposed
for Sema-1a-mediated control of axon
defasciculation during motor axon
guidance in the fly embryo (Paster-
kamp and Kolodkin, 2003).
Although these two studies strongly
suggest that Sema-1a and PlexinA
influenceORNaxon targeting bymedi-
ating axon-axon repulsion, neither
study provides proof that Sema-1a
acts as a repellant; other possible
mechanisms exist. However, in light of
the observed mutant phenotypes and
the well-documented repulsive func-
tions of Semas in general and specifi-
cally of Sema-1a in the fly embryo,
repulsion seems the most likely mech-
anism. Together the elegant genetic
experiments in these two reports
support a major role for Sema-1a
and PlexinA in controlling connection
specificity in the antennal lobe and
highlight the importance of axon-axon
interactions in organizing complex
neural circuits.
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The cellular energy-sensing kinase AMPK is known to be activated in neurons in response to
metabolic insults, but the downstream consequences have been unclear. A study by Kuramoto
and colleagues in this issue of Neuron favors the idea that AMPK activation is neuroprotective,
and suggests a potential mechanism for this effect involving phosphorylation of the GABAB receptor.The nervous system accounts for
a high proportion of total body energy
turnover, and neurons are particularly
vulnerable to energy deficits due totheir rather inflexible metabolism and
poor capacity to store nutrients. It is
therefore not surprising that 50AMP-
dependent protein kinase (AMPK),Neuron 53, Jpart of a signaling system that is a cen-
tral player in the maintenance of en-
ergy balance at both the cellular and
whole body levels, should be highlyanuary 18, 2007 ª2007 Elsevier Inc. 159
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Previewsexpressed in the central nervous sys-
tem (Turnley et al., 1999; Culmsee
et al., 2001). Recent evidence sug-
gests that the AMPK system plays
a key role in the regulation of appetite
and satiety in the hypothalamus, with
the kinase responding to physiological
fluctuations in glucose as well as
agents such as leptin, ghrelin, and
cannabinoids (Kahn et al., 2005). How-
ever, its wider role in the nervous
system has been less clear. There is
general agreement that AMPK is acti-
vated in brain tissue in response to is-
chemia, hypoxia, or glucose depriva-
tion (Culmsee et al., 2001; Gadalla
et al., 2004; McCullough et al., 2005),
but there has been disagreement
about the outcome, with one study
suggesting that it is neuroprotective
(Culmsee et al., 2001), whereas an-
other suggested that it actually exac-
erbates the damage caused by these
insults (McCullough et al., 2005). In ad-
dition, none of these studies identified
the relevant downstream targets for
AMPK in neural tissue. In this issue of
Neuron, Moss and coworkers (Kura-
moto et al., 2007) report new data
supporting the idea that the AMPK
system is neuroprotective and sug-
gesting that the GABAB receptor is
a key mediator of this response (see
Figure 1 for an overview).
AMPK exists as heterotrimeric com-
plexes composed of catalytic a sub-
units and regulatory b and g subunits.
Each of these are encoded by multiple
genes, of which at least five (a1, a2, b1,
b2, and g1) appear to be expressed in
the CNS (Turnley et al., 1999; Culmsee
et al., 2001). AMPK is activated >100-
fold by phosphorylation at T172,
located within the kinase domain of
the a subunits, by upstream kinases.
Binding of AMP to two sites on the g
subunits (Scott et al., 2004) inhibits
dephosphorylation of T172 (Sanders
et al., 2006) and also causes allosteric
activation of the phosphorylated en-
zyme by up to 10-fold; both effects
are antagonized by high concentra-
tions of ATP. AMP is very low in un-
stressed cells because the adenylate
kinase reaction (ATP + AMP4 2ADP)
runs from left to right, driven by the
high cellular ATP:ADP ratio. However,
metabolic stresses that cause a fall in160 Neuron 53, January 18, 2007 ª2007the ATP:ADP ratio will tend to displace
the reaction in a leftward direction and
cause a large increase in AMP. At least
two upstream kinases that phosphory-
late T172, i.e., the LKB1 complex and
the calmodulin-dependent kinase ki-
nases (especially the CaMKKb iso-
form) have recently been identified
(Witters et al., 2005), and both are
highly expressed in the CNS. The
LKB1 complex appears to be constitu-
tively active and provides a constant
low level of T172 phosphorylation
that can be markedly increased in
response to inhibition of dephosphory-
lation when AMP binds to the g sub-
unit. Phosphorylation by CaMKKb, on
the other hand, is triggered by a rise
in Ca2+ and can occur in the absence
of any increase in AMP (Hawley et al.,
2005), although the latter would ac-
centuate the effect if it also occurred.
Consistent with this view, K+-induced
Figure 1. Proposed Upstream Activators
and Downstream Effectors of AMPK in
Neurons under Stress
AMPK is activated either by a rise in Ca2+-acti-
vating CaMKKb, which triggers phosphoryla-
tion of AMPK, or by metabolic stresses that
deplete ATP and increase AMP, leading to inhi-
bition of AMPK dephosphorylation, which op-
poses the effect of either LKB1 or CaMKKb.
Activated AMPK phosphorylates the R2 sub-
unit of the GABAB receptor, promoting the
ability of GABA to activate postsynaptic K+
channels via Gi/Go. Phosphorylation of the
receptor may also cause increased GABA-
dependent inhibition of presynaptic Ca2+
channels, although that has not yet been
directly demonstrated.Elsevier Inc.depolarization of rat brain slices
caused phosphorylation and activa-
tion of AMPK that was sensitive to
the CaMKK inhibitor, STO-609, but
was not associated with changes in
cellular AMP:ATP ratio. Conversely,
treatment with the drug phenformin,
which inhibits the respiratory chain,
caused phosphorylation and activa-
tion of AMPK that was insensitive
to STO-609 and was associated
with large increases in the cellular
AMP:ATP ratio (Hawley et al., 2005).
Although this remains to be properly
tested, one can speculate that the
Ca2+/CaMKK mechanism for AMPK
activation may be the key player dur-
ing periods of intense excitation pro-
duced by normal neural activity, while
the AMP- and LKB1-dependentmech-
anism may become more important
during pathological episodes such as
hypoxia or ischemia.
GABA is the major inhibitory neuro-
transmitter in the vertebratebrain. It ex-
erts rapid effects via ionotropic GABAA
receptors, andmore prolonged, slower
effects via the metabotropic GABAB
class of receptor. While GABAA recep-
tors are extremely diverse, pentameric
complexes encoded by at least 17
genes, GABAB receptors are hetero-
dimers formed from only 2 gene prod-
ucts of the 7 transmembrane helix fam-
ily, i.e., GABABR1 and GABABR2
(Huang, 2006). The R1 subunit con-
tains the GABA binding site, while the
R2 subunit provides the coupling
mechanism to the heterotrimeric G
proteins Gi and Go. The receptors are
coupled via these G proteins primarily
to activation ofK+ channels at postsyn-
aptic sites, where they produce a pro-
longed hyperpolarization, and are cou-
pled to inhibition of Ca2+ channels at
presynaptic sites,where theysuppress
neurotransmitter release. Activation of
GABAB receptors thus suppresses
neuronal excitation bymultiplemecha-
nisms.
Moss and coworkers (Kuramoto
et al., 2007) initiated their project via
a yeast two-hybrid screen of a rat brain
library using the cytoplasmic tail
(C-tail) of GABABR1 as bait, which re-
sulted in the identification of the a1
subunit of AMPK as an interacting pro-
tein. The interaction was confirmed by
Neuron
Previewscoprecipitation analysis of the endog-
enous proteins in rat brain extracts.
Both the a1 and a2 isoforms of
AMPK, and the R1 and R2 subunits
of the receptor, were found to be asso-
ciated together in the same com-
plexes. These proteins also appeared
to colocalize by fluorescence micros-
copy in the neuronal processes of
cultured hippocampal neurons. As
well as forming a complex with the
GABAB receptor, AMPK also appears
to phosphorylate the protein. GST
fusions of the C-terminal tails of both
R1 and R2 were phosphorylated by
endogenous AMPK in rat brain
extracts and by exogenous purified
AMPK. One major site was identified
on R1 (S917) and one on R2 (S783).
To study the possible functional ef-
fects of these phosphorylation events,
Moss and coworkers transiently ex-
pressed R1 and R2 in HEK-293 cells
stably expressing the K+ channels Kir
3.1 and 3.2. Internal perfusion via a
patch pipette (containing ATP and
GTP) initiated a time-dependent run-
down of the K+ current activated by a
submaximal concentration of GABA.
Intriguingly, this rundown was mark-
edly reduced if AMP was included in
the nucleotide solution, an effect that
was lost with R1/R2S783A or
R1S917AR2S783A mutant receptors, but
not with an R1S917AR2 mutant recep-
tor. Similar results were obtained with
endogenous wild-type GABAB recep-
tors activated by baclofen in cultured
hippocampal neurons, where AMPK
was activated using the drug metfor-
min. Overall, these results suggested
that the phosphorylation of S783 on
R2 by AMPK stabilizes the activation
of K+ channels by the GABAB receptor.
The authors went on to study this
phosphorylation further by raising a
phosphospecific antibody (anti-pS783)
against this site. The antibody recog-
nized the GST fusion of the R2 C-ter-
minal tail only after phosphorylation
by AMPK, and also recognized wild-
type R2, but not an S738A mutant, at
the cell surface of HEK-293 cells. The
signal obtained with the cell surface
receptor increased in both the trans-
fected HEK-293 cells and in cultured
hippocampal neurons in response to
the AMPK-activating drug phenformin.The antibodies were also used in im-
munofluorescence studies in cultured
neurons. Double-labeling using anti-
S738A and anti-R2 antibodies re-
vealed that 85% of regions labeled
with the former were also labeled by
the latter, although only 25% of re-
gions labeled with anti-R2 were also
labeled with anti-S783, suggesting
that a large proportion of cellular R2
was not phosphorylated at S783.
To assess whether AMPK was nec-
essary for phosphorylation of S783,
Moss and coworkers expressed by
transfection an inactive mutant of the
a1 subunit of AMPK in cultured hippo-
campal neurons. This acts as a
dominant-negative mutant because
the a subunits are unstable in the ab-
sence of the b and g subunits, and the
inactive a1 competeswith the endoge-
nous, active a subunits for binding to
b and g. Consistent with their hypothe-
sis, the signal obtained with the anti-
pS783 antibody was significantly
decreased in those neurons that also
expressed the transfected, inactive
a1 subunit.
In an attempt to put these findings
into the context of brain injury, the
authors transiently occluded the mid-
dle cerebral artery in rats to cause an
episode of ischemia. Enhanced immu-
noreactivity with anti-pS783 was seen
in the CA3 and dentate gyrus (DG)
regions of the hippocampus, but only
on the injured side of the brain,
whereas immunoreactivitywithaphos-
phorylation-independent R2 antibody
was unaltered in response to ischemia
or injury. Finally, they addressed
whether their novel mechanism exerted
a neuroprotective effect by subjecting
cultured hippocampal neurons to inhi-
bition of catabolism using deoxyglu-
cose plus azide (inhibitors of glycolysis
and oxidative phosphorylation, respec-
tively), which, as expected, caused ac-
tivation of AMPK and phosphorylation
of S783 on R2. When wild-type or
S783A mutants of R2 were expressed
in these cells by nucleofection (which
did not alter the overall level of R2
expression), there was a significant
decrease in survival after a 15 min an-
oxic insult in the cells expressing the
mutant. The effect was small (11%), al-
though the authors argue that this mayNeuron 53,be because the efficiency of transfec-
tion was only about 35%.
These new results support the previ-
ous findings (Culmsee et al., 2001) that
AMPK exerts a neuroprotective effect
during metabolic insults, and do not
support the previous findings suggest-
ing that it exacerbates brain injury
(McCullough et al., 2005). The latter
study is now looking somewhat iso-
lated, and its interpretation is in any
case complicated by the uncertain
specificity of the pharmacological
agents used (C75, compound C, and
AICA riboside). The new findings are
also significant because, for the first
time, a target for AMPspecific to neural
tissue, which can potentially explain
the neuroprotective effect, has been
identified. The authors did not specifi-
cally address whether coupling of the
GABAB receptor to Ca
2+ channels
was also affected, but if the phosphor-
ylation works by promoting coupling
between the receptor and the G pro-
tein, it seems likely that this would be
the case. If so, AMPK activation would
not only accentuate hyperpolarization
in response to the postsynaptic action
of GABA, but it would also promote
its presynaptic effects to inhibit gluta-
mate release.
Although the new results represent
an important step forward, some im-
portant questions and caveats remain.
The sequence around S783 on R2 is
a very poor fit to the consensus recog-
nition motif for AMPK (Scott et al.,
2002). The authors argue that the for-
mation of a complex between AMPK
and the GABAB receptor may allow
a noncanonical site to become phos-
phorylated, but an alternative explana-
tion is that phosphorylation is brought
about by an unidentified kinase that
is activated by AMPK and is a contam-
inant in one or the other of the prepara-
tions used. It should also be pointed
out that, while the anti-pS783 antibody
appears to be specific in western blot-
ting, it is a little risky to extrapolate this
to its use in immunohistochemistry.
One elegant way to confirm the au-
thor’s model would be to create mice
with an S783A knockin mutation of
R2. While this would not be a trivial
undertaking, it should be feasible be-
cause all GABAB receptors appear toJanuary 18, 2007 ª2007 Elsevier Inc. 161
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Previewscontain only R1 and R2, so there
should be no problems of redundancy.
Tissues from these mice would not
only serve as an excellent control for
immunohistochemistry with the anti-
S783 antibody, but one would also
predict that the effect of AMPK activa-
tion on GABAB receptor function, as
well as the neuroprotective effects,
should be lost or reduced. One would
also expect these effects to be lost in
mouse knockouts of the AMPK cata-
lytic subunits. However, since both
a1 and a2 were found to be associated
with the receptor, it may be necessary
to perform a double knockout. A global
double a1/2 knockout is already
known to cause an embryonic lethal
effect, so it may be necessary to
make neuron-specific knockouts ofPaving the Way F
through Phase-R
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Most, if not all, of the neocortex
areas—association versus sens
The study by Lakatos et al. reveal
is reset by somatosensory input
depending on their timing relativ
The integration of information from dif-
ferent sensory systems is a fundamen-
tal characteristic of perception and
cognition—qualitatively different infor-
mation from the various sense organs
is put together in the brain to produce
a unified, coherent representation of
the outside world. Traditionally, it has
been assumed that the integration of
such disparate information was the
task of highly specialized regions
such as the intermediate layers of the
superior colliculus or the association
areas of the neocortex. Recently, how-
ever, there is mounting evidence that
162 Neuron 53, January 18, 2007 ª2007each catalytic subunit and then cross
them.
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and/or somatosensory stimuli (Bruce
et al., 1981). However, numerous hu-
man neuroimaging studies began to
reveal that thereweremany cortical re-
gions, including presumptive unimodal
sensory areas, that seemed to be
multisensory in the sense that they
produced enhanced responses to bi-
modal stimuli relative to unimodal in-
puts. For example, functional imaging
(e.g., Calvert et al., 1997) and, later,
event-related potential (e.g., Giard and
Peronnet, 1999) studies raised the
possibility of audio-visual and audio-
tactile interactions in human auditory
